Incident Report
Subform I: General Information
1. Report Type.
New incident report
Incident Report Number: 2015-3966
2. Registrant Information.
Registrant Reference Number: 20141008
Registrant Name (Full Legal Name no abbreviations): Bayer CropScience Inc.
Address: Suite 200, 160 Quarry Park Blvd SE
City: Calgary
Prov / State: AB
Country: Canada
Postal Code: T2C 3G3
3. Select the appropriate subform(s) for the incident.
Scientific Study
4. Date registrant was first informed of the incident.
5. Location of incident.
6. Date incident was first observed.
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)
PMRA Registration No. 27462
PMRA Submission No.
EPA Registration No.
Product Name: REASON 500SC FUNGICIDE
7. b) Type of formulation.
Application Information
8. Product was applied?
Unknown
9. Application Rate.
10. Site pesticide was applied to (select all that apply).
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform VII: Scientific Study
1. Study Reference
Title Fenamidone SC 500 G - Assessment of Chronic Effects to the Honeybee, Apis mellifera L., in a 10 Days Continuous Laboratory Feeding Test
Date 22-NOV-13
2. a) Is an extension needed to translate the document?
No
3. Type of incident identified in the study
Increased health or environmental risk
4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)
BCS is submitting new information to PMRA related to Fenamidone SC 500 Fungicide. The results of this study represent new information with respect to the chronic effects of this fungicide to honey bees. This information is not necessarily a new adverse effect of the subject chemical, but is rather new information submitted for the agencys own review.
5. a) Was the study discontinued before completion?
No
5. b) Provide the reason for discontinuation
6. If the study is ongoing, what is the expected completion date?
For Registrant use only
7. Provide supplemental information here